Radiofrequency Ablation of Metastatic Pheochromocytoma

被引：32

作者：

Venkatesan, Aradhana M. ^{[1
]}

Locklin, Julia ^{[1
]}

Lai, Edwin W. ^{[2
]}

Adams, Karen T. ^{[2
]}

Fojo, Antonio Tito ^{[3
]}

Pacak, Karel ^{[2
]}

Wood, Bradford J. ^{[1
]}

机构：

[1] NIH, Dept Radiol & Imaging Sci, Ctr Clin, Ctr Intervent Oncol, Bethesda, MD 20892 USA

[2] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Med Neuroendocrinol, Bethesda, MD USA

[3] NCI, Expt Therapeut Sect, Med Oncol Branch, Bethesda, MD 20892 USA

来源：

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY | 2009年 / 20卷 / 11期

基金：

美国国家卫生研究院;

关键词：

MALIGNANT PHEOCHROMOCYTOMA; METYROSINE; MANAGEMENT; TUMORS;

D O I：

10.1016/j.jvir.2009.07.031

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

100231 [临床病理学]; 100902 [航空航天医学];

摘要：

In the present report on the preliminary safety and effectiveness of radiofrequency (RF) ablation for pheochromocytoma metastases, seven metastases were treated in six patients (mean size, 3.4 cm; range, 2.2-6 cm). alpha- and beta-adrenergic and catecholamine synthesis inhibition and intraprocedural anesthesia monitoring were used. Safety was assessed by recording ablation-related complications. Complete ablation was defined as a lack of enhancement within the ablation zone on follow-up computed tomography. No serious adverse sequelae were observed. Complete ablation was achieved in six of seven metastases (mean follow-up, 12.3 months; range, 2.5-28 months). In conclusion, RF ablation may be safely performed for metastatic pheochromocytorna given careful attention to peri-procedural management.

引用

页码：1483 / 1490

页数：8

共 22 条

[1]

Hypertensive crisis in a patient undergoing percutaneous radiofrequency ablation of an adrenal mass under general anesthesia [J].

Chini, EN ;

Brown, MJ ;

Farrell, MA ;

Charboneau, JW .

ANESTHESIA AND ANALGESIA, 2004, 99 (06) :1867-1869

[2]

Malignant pheochromocytoma: current status and initiatives for future progress [J].

Eisenhofer, G ;

Bornstein, SR ;

Brouwers, FM ;

Cheung, NKV ;

Dahia, PL ;

de Krijger, RR ;

Giordano, TJ ;

Greene, LA ;

Goldstein, DS ;

Lehnert, H ;

Manger, WM ;

Maris, JM ;

Neumann, HPH ;

Pacak, K ;

Shulkin, BL ;

Smith, DI ;

Tischler, AS ;

Young, WF .

[3]

EISENHOFER G, 1986, CLIN CHEM, V32, P2030

[4]

Adverse drug reactions in patients with phaeochromocytoma - Incidence, prevention and management [J].

Eisenhofer, Graeme ;

Rivers, Graham ;

Rosas, Alejandro L. ;

Quezado, Zena ;

Manger, William M. ;

Pacak, Karel .

DRUG SAFETY, 2007, 30 (11) :1031-1062

[5]

Clinical experience over 48 years with pheochromocytoma [J].

Goldstein, RE ;

O'Neill, JA ;

Holcomb, GW ;

Morgan, WM ;

Neblett, WW ;

Oates, JA ;

Brown, N ;

Nadeau, J ;

Smith, B ;

Page, DL ;

Abumrad, NN ;

Scott, HW .

ANNALS OF SURGERY, 1999, 229 (06) :755-764

[6]

Pheochromocytomas: Can malignant potential be predicted? [J].

John, H ;

Ziegler, WH ;

Hauri, D ;

Jaeger, P .

UROLOGY, 1999, 53 (04) :679-683

[7]

Phaeochromocytoma [J].

Lenders, JWM ;

Eisenhofer, G ;

Mannelli, M ;

Pacak, K .

LANCET, 2005, 366 (9486) :665-675

[8]

Percutaneous CT-guided radiofrequency ablation of symptomatic bilateral adrenal metastases in a single session [J].

Lo, WK ;

vanSonnenberg, E ;

Shankar, S ;

Morrison, PR ;

Silverman, SG ;

Tuncali, K ;

Rabin, M .

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 17 (01) :175-179

[9]

Radiofrequency Ablation and Biopsy of Metastatic Pheochromocytoma: Emphasizing Safety Issues and Dangers [J].

Mamlouk, Mark D. ;

vanSonnenberg, Eric ;

Stringfellow, Gregory ;

Smith, Dean ;

Wendt, Albert .

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2009, 20 (05) :670-673

[10]

A survey on adrenal incidentaloma in Italy [J].

Mantero, F ;

Terzolo, M ;

Arnaldi, G ;

Osella, G ;

Masini, AM ;

Alì, A ;

Giovagnetti, M ;

Opocher, G ;

Angeli, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) :637-644

← 1 2 3 →